Short answer
Prioritize spatial efficiency in the design of blister packaging to minimize material usage and waste.
- Field
- Resource Management
- Source
- European Journal of Clinical Pharmacology (2023)
- Method
- Quantitative analysis and material measurement
- Sample
- Analysis of 45 distinct solid oral dosage forms (SODF) from the 50 most frequently prescribed medicines.
- Evidence
- Strong effect
Reconfiguring the spatial arrangement of individual medication doses within blister packaging can significantly decrease the amount of composite material waste generated. This resource management research insight is drawn from a 2023 study published in European Journal of Clinical Pharmacology. Using Quantitative analysis and material measurement with Analysis of 45 distinct solid oral dosage forms (SODF) from the 50 most frequently prescribed medicines., researchers explored how this design variable affects real-world outcomes. The key design takeaway: Prioritize spatial efficiency in the design of blister packaging to minimize material usage and waste.
Optimizing Blister Pack Layout Can Reduce Pharmaceutical Waste by 37%
Reconfiguring the spatial arrangement of individual medication doses within blister packaging can significantly decrease the amount of composite material waste generated.
European Journal of Clinical Pharmacology · 2023
Key Findings
- 0169% of the material in current blister packaging is used for the space between individual doses.
- 02Aluminum-aluminum alveoli were found to be more than four times larger than the actual medication dose.
- 03Optimizing the layout to a 2mm sealing area around each alveolus and arranging doses in two rows could save approximately 37% of the composite waste.
Application
Design takeaway
Prioritize spatial efficiency in the design of blister packaging to minimize material usage and waste.
How to apply
When designing or redesigning blister packaging, conduct a spatial analysis to determine the minimum required spacing and explore multi-row configurations to reduce overall material consumption.
Project actions
- 01Consider the 'empty space' in your designs – is it truly necessary?
- 02Explore different arrangements of components to see if they can be packed more efficiently.
Method & Evidence
Variables
Strengths & Limitations
Strengths
- +Quantifies a specific, actionable waste reduction strategy.
- +Focuses on a widely used packaging format.
Limitations
The study assumes that the manufacturing process can accommodate the optimized layouts without significant cost increases or quality issues.
Reliability & validity
The study's validity is supported by detailed measurements and calculations. Reliability would depend on consistent measurement techniques and the representativeness of the selected sample of medicines.
Think critically
Beyond material reduction, what other environmental or user-related factors might be impacted by altering the spacing and layout of blister packs?
Design Principles
"Minimize void space in packaging through optimized component arrangement."
This research highlights a readily implementable strategy for reducing environmental impact within the pharmaceutical packaging sector. By focusing on design optimization rather than complex material science or new technologies, substantial material savings can be achieved with immediate effect.
What This Means for Your Design
You can save a lot of plastic and metal by just arranging the pills closer together in their packaging.
How to use in your project
- 1.Use this research to justify investigating packaging optimization as a method for reducing waste in your own design project.
Add to My Project
Quick Cite
Paragraph starter
Research by Falconnier-Williams et al. (2023) demonstrates that optimizing the spatial arrangement of doses within blister packaging can lead to substantial reductions in material waste, with potential savings of up to 37% by minimizing unnecessary gaps. This highlights the significant environmental benefits achievable through thoughtful packaging layout design.
Source
European Journal of Clinical Pharmacology
Untapped options to reduce waste from blister packaging for tablets and capsules
journal · 2023
View sourceQuestions About This Research
- What does the research say about optimizing blister pack layout can reduce pharmaceutical waste by 37%?
- Prioritize spatial efficiency in the design of blister packaging to minimize material usage and waste. Evidence: European Journal of Clinical Pharmacology (2023).
- Why does "Optimizing Blister Pack Layout Can Reduce Pharmaceutical Waste by 37%" matter for design?
- This research highlights a readily implementable strategy for reducing environmental impact within the pharmaceutical packaging sector. By focusing on design optimization rather than complex material science or new technologies, substantial material savings can be achieved with immediate effect.
- How can designers apply this research?
- Prioritize spatial efficiency in the design of blister packaging to minimize material usage and waste.
- What were the main findings?
- 69% of the material in current blister packaging is used for the space between individual doses.. Aluminum-aluminum alveoli were found to be more than four times larger than the actual medication dose.. Optimizing the layout to a 2mm sealing area around each alveolus and arranging doses in two rows could save approximately 37% of the composite waste.
- What research method was used?
- Quantitative analysis and material measurement with Analysis of 45 distinct solid oral dosage forms (SODF) from the 50 most frequently prescribed medicines..
- How strong is the evidence?
- Evidence strength is rated Strong effect, based on a 2023 journal from European Journal of Clinical Pharmacology.
- What should I do differently in my next project?
- When designing or redesigning blister packaging, conduct a spatial analysis to determine the minimum required spacing and explore multi-row configurations to reduce overall material consumption.
- What are the limitations?
- The study focused on specific medication types and the German market; results may vary for different drug forms or geographical regions. It does not account for potential manufacturing complexities of optimized layouts.